Brief: ANI Pharmaceuticals Announces FDA Approval And Launch Of Indomethacin Oral Suspension, USP
16/01/2024 11:51
Jan 16 (Reuters) - ANI Pharmaceuticals Inc ANIP.O :
* ANI PHARMACEUTICALS ANNOUNCES THE FDA APPROVAL AND LAUNCH
OF
INDOMETHACIN ORAL SUSPENSION, USP
Source text for Eikon: ID:nGNX9sPRmV
Further company coverage: ANIP.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on ANI Pharmaceuticals
See all newsBrief: Ani Pharmaceuticals Announces The Launch Of Duloxetine Delayed-Release Capsules
Brief: Ani Pharmaceuticals Announces The FDA Approval Of Everolimus Tablets For Oral Suspension
Brief: Ani Pharmaceuticals Appoints Henry Gosebruch To Board Of Directors
U.S. RESEARCH ROUNDUP-Compass Minerals, Duke Energy, Tesla
ANI Pharmaceuticals, Inc. reports results for the quarter ended June 30 - Earnings Summary